- Home
- LRFC vs CNTB Comparison
LRFC vs CNTB Comparison
Compare LRFC & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRFC
- CNTB
- Stock Information
- Founded
- LRFC 2013
- CNTB 2012
- Country
- LRFC United States
- CNTB United States
- Employees
- LRFC N/A
- CNTB N/A
- Industry
- LRFC Finance: Consumer Services
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- LRFC Finance
- CNTB Health Care
- Exchange
- LRFC Nasdaq
- CNTB Nasdaq
- Market Cap
- LRFC 50.2M
- CNTB 44.2M
- IPO Year
- LRFC 2013
- CNTB 2021
- Fundamental
- Price
- LRFC $18.86
- CNTB $1.05
- Analyst Decision
- LRFC
- CNTB Strong Buy
- Analyst Count
- LRFC 0
- CNTB 2
- Target Price
- LRFC N/A
- CNTB $7.50
- AVG Volume (30 Days)
- LRFC 11.1K
- CNTB 92.2K
- Earning Date
- LRFC 08-07-2025
- CNTB 05-15-2025
- Dividend Yield
- LRFC 7.56%
- CNTB N/A
- EPS Growth
- LRFC N/A
- CNTB N/A
- EPS
- LRFC N/A
- CNTB N/A
- Revenue
- LRFC $20,544,000.00
- CNTB $26,033,000.00
- Revenue This Year
- LRFC N/A
- CNTB N/A
- Revenue Next Year
- LRFC N/A
- CNTB N/A
- P/E Ratio
- LRFC N/A
- CNTB N/A
- Revenue Growth
- LRFC 3.11
- CNTB N/A
- 52 Week Low
- LRFC $16.57
- CNTB $0.51
- 52 Week High
- LRFC $26.00
- CNTB $1.73
- Technical
- Relative Strength Index (RSI)
- LRFC 56.05
- CNTB 64.42
- Support Level
- LRFC $18.53
- CNTB $0.91
- Resistance Level
- LRFC $19.00
- CNTB $1.07
- Average True Range (ATR)
- LRFC 0.39
- CNTB 0.09
- MACD
- LRFC 0.18
- CNTB 0.00
- Stochastic Oscillator
- LRFC 77.87
- CNTB 76.47
About LRFC Logan Ridge Finance Corporation
Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.